The nonobese diabetic (NOD) mouse strain has a genetic deficiency in natural killer (NK) cells. This defect underlies this strain's utility in several experimental settings; in particular, it promotes engraftment of human tissue in NOD hosts during the generation of "humanized" mouse models. We have mapped the major NK-cell defect in the NOD vs. C57BL/6 (B6) strain to an inadequately expressed Il15 allele. Treatment of NOD mice with a reagent that specifically enhances interleukin (IL)-15 bioavailability normalized NK-cell numbers and activity in the absence of nonspecific stimulation. These findings raise the possibility of exploiting reagents that impact the IL-15 receptor pathway to facilitate construction of humanized mouse models on non-NOD genetic backgrounds.
The nonobese diabetic (NOD) mouse strain has a genetic deficiency in natural killer (NK) cells. This defect underlies this strain's utility in several experimental settings; in particular, it promotes engraftment of human tissue in NOD hosts during the generation of "humanized" mouse models. We have mapped the major NK-cell defect in the NOD vs. C57BL/6 (B6) strain to an inadequately expressed Il15 allele. Treatment of NOD mice with a reagent that specifically enhances interleukin (IL)-15 bioavailability normalized NK-cell numbers and activity in the absence of nonspecific stimulation. These findings raise the possibility of exploiting reagents that impact the IL-15 receptor pathway to facilitate construction of humanized mouse models on non-NOD genetic backgrounds. type 1 diabetes | gene mapping | cytotoxicity | genetic variation I t is well known that the nonobese diabetic (NOD) mouse strain has a genetic deficiency in natural killer (NK) cell activity (1) (2) (3) (4) (5) (6) (7) (8) (9) . The earliest indication of such a defect was the observation that NOD splenocytes have a reduced ability to kill YAC-1 targets in vitro (1, 2) . More recently, with the molecular definition of NK receptors and their ligands, coupled with their genetic localization, it became clear that NOD mice have an unusual repertoire of molecules critical for the differentiation, survival, and activity of NK cells; for example, a unique NK complex (NKC) on chromosome (chr) 6 (7, 10) , or reduced levels of NKG2D, owing to enhanced expression of its ligand, Rae 1, and resulting desensitization (6, 11) . However, the root of the genetic deficiency in NK cell activity has not yet been identified.
Whatever its origin, the NOD NK cell defect has important functional manifestations. First, it has long been exploited to promote engraftment of human tissues during the generation of "humanized" mouse models, explaining the popularity of the NOD strain or its genetic derivatives in such contexts (2) . In addition, NOD mice spontaneously develop a slowly programming form of type 1 diabetes (T1D), and their compromised NK-cell compartment protects from the hyperacute diabetes provoked by certain genetic or immune manipulations, such as introduction of the BDC2.5 T cell receptor (TCR) transgenes onto the B6 genetic background (7), blockade of CTLA-4 (7), or ectopic expression of an IFN-β transgene in pancreatic islets (8) .
Our goal here was to genetically map the NK cell defect of NOD mice and to validate the functional implication of the culprit gene.
Results and Discussion
We chose B6.H-2 g7 (B6g7) mice, congenic for the NOD-derived major histocompatibility complex (MHC), as comparators for mapping the NOD NK-cell defect. The two mouse strains had similar fractions of CD49b + CD3 − NK cells in the spleen and other lymphoid organs, as previously reported (5, 9) , with similar maturation (CD27 vs. CD11b) and activation (CD25 vs. CD69) profiles (Fig. S1 ). However, largely reflecting the unique structure of the NK complex on chr 6 in NOD mice (10), the two strains had very different patterns of NK-cell receptor expression, e.g., of NK1.1, Ly49I, Ly6c, and NKG2A (Fig. S1 ).
We quantified two parameters in the genetic mapping studies. "NK numbers" refers to the percentage of CD49b + CD3 − cells in total splenocytes and hovered around 2% in both strains (Fig.  1A) . "NK activity" was measured by an in vivo assay (3, 5 ) that compared the survival of coinjected MHCI-positive and -negative target cells over an 18-h assay period, yielding a cytotoxicity index (Fig. 1B) . Routinely, about 2-to 3-fold fewer of the MHCInegative targets were killed in NOD than in B6g7 mice (Fig. 1C) .
NOD × B6g7 F 1 offspring had NK numbers indistinguishable from those of the two parental strains ( Fig. 2A) , whereas their NK activity was relatively high, as in B6g7 animals ( Fig. 2B ), indicating that this phenotype is dominant. Unexpectedly, average NK numbers in a cohort of 187 NOD × B6g7 F 2 offspring were higher than in both of the parental strains or in the F 1 's ( Fig. 2A) , suggesting that counterbalancing positive and negative influences are encoded in the NOD and B6g7 genomes. Individual F 2 's showed a broad range of NK cytotoxicity indices (Fig. 2B) , arguing for polygenic control of this trait. There was only a poor correlation between the NK number and activity values (Fig. 2C) , meaning that at least some of the loci controlling these traits operate independently.
Genomewide single-nucleotide polymorphism (SNP) genotyping was performed on this F 2 cohort and was analyzed relative to both NK numbers and activity. The data on NK numbers yielded a major peak of linkage on chr 8, with a LOD score of 7.4, well above the significance threshold of 3.3 determined by permutation testing (Fig. 2D i) . The chr 8 linkage was broad, extending from 30 to 100 Mb and peaking at 65 Mb (Fig. 2D ii) . The NOD haplotype in this region was correlated with lower NK-cell numbers (Fig. 2D iii) . Joint LOD scores, calculated to assess epistatic influences (12) , revealed interactions between the chr 8 interval and loci residing on several other chromosomes ( Fig. 2E i, detailed in the legend to this figure) . For example, the chr 9 locus had a strong negative impact on the chr 8 effect, the allele at chr 9 largely counteracting the B6 allele at chr 8 ( Fig. 2E ii), which can easily explain why average NK numbers end up being very similar in NOD and B6g7 mice.
Intervals on chrs 1, 6, and 8 showed significant linkage to NK activity, i.e., had a LOD score >3.5 ( Fig. 2F i and ii) . The chr 8 interval had the strongest effect, with a directionality consistent with it being responsible for the low NK-cell activity of the NOD strain (Fig.  2F iii) . The analysis of joint LOD scores revealed that the chr 1 and chr 6 regions both had an epistatic interaction with the interval on chr 8, as well as with each other (Fig. 2G i) . The dampening effect of the NOD chr 8 allele on NK-cell performance was reduced when the chr 1 interval was NOD/B6 and was almost completely masked when that interval was NOD/NOD ( Fig. 2G ii Left). In contrast, the negative impact of the chr 8 allele was most evident when the chr 6 interval was present in NOD-homozygous state (Fig. 2G ii Right). Because the chr 1 and chr 6 genetic influences did not drive NK activity in the relevant direction, i.e., the B6 haplotype was associated with lower activity, we did not further pursue their localization. However, given the unique structure of the NK complex in NOD mice (10) , one or more of its genes are likely candidates for the chr 6 effect. One obvious candidate for the chr 1 locus is the gene encoding 2B4 (Cd244), which is active in NK cells, or more generally the SLAM/CD2 gene cluster, of which NOD mice carry an unusual haplotype (13) . (Fig. 3A Left) . Also anticipated was that the NOD.C8 b/b line would exhibit the relatively high NK activity characteristic of the B6g7 strain, which would be further augmented in the double-congenic line, given the epistatic interaction between the chr 1 and chr 8 intervals mentioned above (Fig. 3A Right) . (The increased activity of NOD.C1 b/b vis-à-vis NOD mice probably reflects epistatic interactions between loci on chr1 and other chromosomes.)
Exploiting these congenic lines, we addressed whether the NOD NK-cell defect specified by the chr 8 interval partitioned with the radio-resistant stromal-cell compartment, with the radio-sensitive hematopoietic cell compartment, or intrinsically within NK cells (Fig. 3B) . First, we transferred bone-marrow cells from NOD mice carrying the CD45.2 allelic marker into lethally irradiated NOD or NOD.C8 b/b hosts, both bearing the CD45.1 allele, and quantified NK-cell numbers 7 weeks later. There was no difference in the fraction of NK cells in the spleens of the two types of host (Fig. 3C) , indicating that the dampening effect of the NOD chr 8 segment was not determined by the stromal, but rather by the hematopoietic cell compartment. Secondly, we performed a similar experiment, but transferred an equal mix of NOD.CD45. 2 (Fig. 3D) , establishing that the impact of the NOD chr 8 allele was not NK-cell intrinsic and was thus determined by other lymphoid or myeloid cells.
The congenic lines were also the starting point for finer mapping within the chr 8 interval. Crossing the NOD.C1 b/b and NOD. C1 b/b 8 b/b mice (following an intercross/backcross strategy to generate mice with a single recombinant chr 8) yielded 147 offspring with recombination events within the 65.7-110.0 Mb interval, while fixing the epistatic B6 segment on chr 1. SNP mapping on this cohort generated almost identical curves for NK numbers and activity, peaking between 76 and 91 Mb (Fig. 4A) . From these, we established three subcongenic lines with recombination points within the interval (Fig. 4B) . F 80 and F 83 mice had relatively low NK numbers and activity values similar to those of the NOD.C1 b/b comparator, whereas F 85 mice had the higher numbers and activity characteristic of NOD.C1 b/b 8 b/b and B6g7 mice (Fig. 4C) . Thus, the major NK-cell defect in NOD mice maps between positions 83 and 85 Mb on chr 8. According to the Ensembl database, seven protein-coding genes reside within this interval (Fig. 4D) . A microarray comparison of gene expression by splenocytes from B6g7 and NOD mice (Affymetrix M430, triplicate) revealed that the locus encoding the cytokine, IL-15, was expressed most differentially between the two strains-about 2-fold less by NOD splenocytes (Fig. 4E) .
Given its well-known roles in NK-cell maturation, survival, and activity, IL-15 makes an excellent candidate for the molecule responsible for the NK-cell defect in the NOD strain. We sequenced the exons and promoter region of the Il15 genes from B6g7 and NOD mice, uncovering 18 SNPs: 8 in the promoter region, 5 in the 5′-UTR, and 5 in the 3′-UTR (Fig. 5A ). As none of the SNPs alter the protein sequence, we focused on differential IL-15 expression in the two strains. RT-PCR analysis confirmed that there were reduced IL-15 transcript levels in the spleens of NOD mice and that this was also true of the two known splice variants (Fig. 5B) . Expression-QTL (eQTL) analysis, using spleen RNA from the same F 2 offspring used for mapping the NK numbers/activity QTLs, revealed that the differential in IL-15 expression was cisdetermined (Fig. 5C ). According to RT-PCR analysis on sorted splenocyte populations, dendritic cells and macrophages showed the highest IL-15 transcript levels and the greatest differential between NOD and B6g7 mice (Fig. 5D) , consistent with the above conclusion that the NK-cell defect was dictated by non-NK hematopoetic cells (Fig. 3B) . Soluble IL-15 has little in vivo activity on its own; rather, it is usually bound to the IL-15 receptor α (IL15Rα) chain, mostly on dendritic cells, and "presented" in trans to NK (and other) cells (14) . Complexing IL-15 with IL15RαFc stabilizes it, promoting its bioavailability (15) (16) (17) . To see whether "IL-15 complexes" could boost NOD NK-cell numbers and activity to B6g7 levels, we injected NOD mice with differing amounts in differing ratios every other day for 8 days, and assayed NK-cell properties. Serial injections of 25 ng IL-15 complexed with 100 ng IL-15RαFc produced the desired few-fold increase in NK numbers and activity (Fig. 6A) . We also applied this regimen to the simplified (TCR transgenic) T1D model, BDC2.5/NOD, of which 15-25% normally develop diabetes beginning at 15-20 weeks of age. As with the standard NOD strain, IL-15 complexes boosted NK-cell numbers in the spleens of BDC2.5/NOD mice a few-fold and also in the pancreatic lymph nodes and the islet infiltrate (Fig. 6B i) . However, according to their profiles of CD69 and CD25 expression, the NK cells in complex-injected mice were not unduly activated (Fig. 6B ii) . The increase in cell numbers at these doses was quite specific for the NK-cell compartment, as no augmentation in numbers of CD4 + (Fig. 6B iii) . Strikingly, beginning as soon as 2 weeks after the first injection, about 30% of the BDC2.5/NOD mice administered IL-15 complexes every other day starting at 14 days of age developed diabetes, i.e., long before they normally would (Fig. 6B iv) . This effect evokes previously described associations between numbers or activity of NK cells and hyperacute diabetes in mouse models (7, 8) .
Thus, inadequate expression of the Il15 gene is a major contributor to the NK-cell defect in NOD mice. IL-15 regulates the maturation and survival of NK cells and also controls their activity by up-regulating expression of NK receptors and cytotoxic effector molecules (18) . Whereas our genetic dissection revealed Il15 to have an important impact on both the numbers and activity of NK cells, several other loci also influenced these properties. The integration of these different effects, which could be either positive or negative and could alter numbers and activity independently, led to normal NK-cell numbers with 50-70% reduced activity in the NOD compared with the B6g7 strain. Although we did not investigate these aspects, IL-15's known influence on other cell types (18) has the potential of explaining certain other aberrant characteristics of the NOD strain, e.g., deficiencies in the NK-T or dendritic cell compartments (19, 20) .
Materials and Methods
Mice. NOD/LtDOI (NOD), C57BL/6.H-2.g7 (B6g7), and BDC2.5 T cell receptor transgenic mice on the NOD and B6g7 backgrounds (BDC2.5/NOD and BDC2.5/ Bg7, respectively) were bred in our specific-pathogen-free facility at Joslin Diabetes Center (protocol 99-20). F 2 mice were generated by intercrossing , and NOD.C8 b/b mice were backcrossed to the NOD genetic background more than six times. For bone-marrow chimeras, 6-week-old recipient mice were irradiated at 900 R, reconstituted with 3.10 6 cells harvested from the femur of agematched donor mice. After 6 weeks, chimeras were tested by flow cytometry for the degree of chimerism (routinely >90% of donor origin).
Analysis of Lymphoid Cell Populations. Cell suspensions were generated by mechanical disruption and stained for flow cytometry. RNA was prepared from sorted cell populations or whole spleens as described (21) . cDNAs were quantified by using SYBR Green quantitative RT-PCR. For microarrays, RNA was amplified (MessageAmp aRNA, Ambion), biotin-labeled (BioArray high yield RNA transcription labeling, Enzo), purified (RNeasy minikit, QIAGEN), and hybridized to M430 2.0 chips (Affymetrix). Raw data were normalized with the RMA algorithm in the GenePattern software package (22) .
In Vivo Cytotoxicity Assay. 
